Ben Lamm
Showing 1–2 of 2 transcripts.
Race to Save Humanity: Inside $12B Colossal Biosciences & $3.8B Astromech
Ben Lamm, George Church, Molly O'Shea
Colossal is leveraging a de-extinction toolkit and AI-driven "civilization tech" to address an impending 50% global biodiversity loss while raising $400 million in recent capital. Following a breakthrough in generating healthy woolly mice for rapid phenotype testing, the company aims to birth its first extinct species within 12 months by utilizing an 80% efficient cloning arm and open-source technologies. This vertical integration strategy targets ethical textile production and invasive species eradication, operating under strict ethical boundaries that exclude human or primate genome editing.
- Goldman Sachs34 min
Colossal Biosciences’ Ben Lamm sees ‘de-extinction’ as vital to fighting climate change
Ben Lamm, Amit Sinha, George Church
Co-founded by CEO Ben Lamb and geneticist George Church, Colossal Biosciences leverages multiplex CRISPR editing to restore extinct species like the woolly mammoth as functional tools for Arctic climate mitigation and biodiversity preservation. The company has secured $225 million in funding to execute a for-profit model generating revenue through carbon credits and ecological services, while simultaneously advancing spin-off technologies in artificial wombs and human medicine. By reintroducing megafauna to the Arctic, Colossal aims to lower ground temperatures and store carbon, with subsequent targets including the Thylacine and Dodo to address global ecological voids.